- ISIN
- US8636671013
- CUSIP
- 863667101
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Feb 1, 1988
Highlights
- Market Cap
- $117.76B
- Enterprise Value
- $143.33B
- EPS (TTM)
- $8.63
- PE Ratio
- 35.29
- PEG Ratio
- 2.62
- Total Revenue (TTM)
- $25.27B
- Gross Profit (TTM)
- $16.09B
- EBITDA (TTM)
- $5.48B
- Year Range
- $281.00 - $404.87
- Target Price
- $428.67
- ROA (TTM)
- 7.21%
- ROE (TTM)
- 7.21%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SYK Performance Chart
Stryker Corporation (SYK) is down 13.1% since the beginning of the year. At $305 per share, SYK is trading 24.7% below its 52-week high of $405. Investors who bought $1,000 worth of SYK shares 5 years ago would now be looking at an investment worth $1,222.
Loading charts...
Returns By Period
Stryker Corporation (SYK) has returned -13.08% so far this year and -18.09% over the past 12 months. Over the last ten years, SYK has returned 11.31% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Stryker Corporation
- 1D
- -1.01%
- 1M
- -3.73%
- YTD
- -13.08%
- 6M
- -14.09%
- 1Y
- -18.09%
- 3Y*
- 1.74%
- 5Y*
- 4.09%
- 10Y*
- 11.31%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
SYK Monthly Returns History
Based on dividend-adjusted daily data since Feb 1, 1988, SYK's average daily return is +0.08%, while the average monthly return is +1.67%. At this rate, an investment would double in approximately 3.5 years.
Historically, 58% of months were positive and 42% were negative. The best month was Dec 1991 with a return of +34.4%, while the worst month was Nov 2008 at -27.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, SYK closed higher 50% of trading days. The best single day was Apr 21, 1999 with a return of +27.2%, while the worst single day was Jan 28, 2000 at -17.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.15% | 4.84% | -14.96% | -4.10% | -3.19% | -0.13% | -13.08% | ||||||
| 2025 | 8.68% | -1.30% | -3.39% | 0.45% | 2.33% | 3.62% | -0.73% | -0.34% | -5.34% | -3.63% | 4.19% | -5.07% | -1.48% |
| 2024 | 12.03% | 4.05% | 2.76% | -5.97% | 1.36% | -0.01% | -3.76% | 10.07% | 0.46% | -1.38% | 10.07% | -7.97% | 21.34% |
| 2023 | 3.81% | 3.57% | 8.89% | 4.97% | -8.03% | 10.99% | -7.11% | 0.05% | -3.35% | -1.12% | 9.66% | 1.33% | 23.80% |
| 2022 | -7.24% | 6.17% | 1.78% | -9.76% | -2.80% | -14.87% | 7.95% | -4.45% | -0.96% | 13.18% | 2.03% | 4.86% | -7.42% |
| 2021 | -9.81% | 9.81% | 0.63% | 7.82% | -2.80% | 1.99% | 4.32% | 2.27% | -4.60% | 0.89% | -11.06% | 13.30% | 10.22% |
Benchmark Metrics
Stryker Corporation has an annualized alpha of 13.17%, beta of 0.82, and R2 of 0.22 versus S&P 500 Index. Calculated based on daily prices since February 01, 1988.
- This stock captured 118.64% of S&P 500 Index gains but only 80.93% of its losses - a favorable profile for investors.
- R2 of 0.22 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 13.17%
- Beta
- 0.82
- R²
- 0.22
- Upside Capture
- 118.64%
- Downside Capture
- 80.93%
Return for Risk
Risk / Return Rank
SYK ranks 12 for risk / return — in the bottom 12% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Stryker Corporation (SYK) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SYK | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.82 | ||
| Sortino ratioReturn per unit of downside risk | -3.78 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 1.37 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | -0.62 | 2.78 | -3.40 |
| Martin ratioReturn relative to average drawdown | -1.40 | 12.44 | -13.84 |
Dividends
Dividend History
Stryker Corporation provided a 1.13% dividend yield over the last twelve months, with an annual payout of $3.44 per share. The company has been increasing its dividends for 16 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $3.44 | $3.40 | $3.24 | $3.05 | $2.84 | $2.59 | $2.36 | $2.14 | $1.93 | $1.75 | $1.57 | $1.42 |
Dividend yield | 1.13% | 0.97% | 0.90% | 1.02% | 1.16% | 0.97% | 0.96% | 1.02% | 1.23% | 1.13% | 1.31% | 1.52% |
Monthly Dividends
The table displays the monthly dividend distributions for Stryker Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.88 | $0.00 | $0.00 | $0.00 | $0.88 | ||||||
| 2025 | $0.00 | $0.00 | $0.84 | $0.00 | $0.00 | $0.84 | $0.00 | $0.00 | $0.84 | $0.00 | $0.00 | $0.88 | $3.40 |
| 2024 | $0.00 | $0.00 | $0.80 | $0.00 | $0.00 | $0.80 | $0.00 | $0.00 | $0.80 | $0.00 | $0.00 | $0.84 | $3.24 |
| 2023 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.80 | $3.05 |
| 2022 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.75 | $2.84 |
| 2021 | $0.00 | $0.00 | $0.63 | $0.00 | $0.00 | $0.63 | $0.00 | $0.00 | $0.63 | $0.00 | $0.00 | $0.70 | $2.59 |
Dividend Yield & Payout
Dividend Yield
Stryker Corporation has a dividend yield of 1.13%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Stryker Corporation has a payout ratio of 38.48%, which is quite average when compared to the overall market. This suggests that Stryker Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Stryker Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Stryker Corporation was 58.63%, occurring on Mar 9, 2009. Recovery took 1140 trading sessions.
The current Stryker Corporation drawdown is 23.93%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -58.63%Mar 2009 | 1y 2mo | 4y 6mo | 5y 8moDec 2007 - Sep 2013 |
1993 bear market1993 | -57.00%Jun 1993 | 1y 5mo | 2y 5mo | 3y 11moDec 1991 - Nov 1995 |
COVID crash2020 | -43.80%Mar 2020 | 1mo 2d | 6mo 20d | 7mo 22dFeb 2020 - Oct 2020 |
Dot-com crash2000–2002 | -35.95%Mar 2000 | 1mo 18d | 3mo 8d | 4mo 26dJan 2000 - Jun 2000 |
1998 bear market1998 | -35.43%Oct 1998 | 5mo 26d | 2mo 15d | 8mo 11dApr 1998 - Dec 1998 |
Drawdown Indicators
| SYK | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.63% | -56.78% | -1.85% |
Max Drawdown (1Y)Largest decline over 1 year | -29.45% | -9.10% | -20.35% |
Max Drawdown (3Y)Largest decline over 3 years | -29.45% | -18.90% | -10.55% |
Max Drawdown (5Y)Largest decline over 5 years | -31.68% | -25.43% | -6.25% |
Max Drawdown (10Y)Largest decline over 10 years | -43.80% | -33.92% | -9.88% |
Current DrawdownCurrent decline from peak | -23.93% | -1.80% | -22.13% |
Average DrawdownAverage peak-to-trough decline | -13.11% | -10.71% | -2.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.92% | 2.03% | +10.89% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Stryker Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Stryker Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for SYK, comparing it with other companies in the Medical Devices industry. Currently, SYK has a P/E ratio of 35.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for SYK compared to other companies in the Medical Devices industry. SYK currently has a PEG ratio of 2.6. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SYK relative to other companies in the Medical Devices industry. Currently, SYK has a P/S ratio of 4.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SYK in comparison with other companies in the Medical Devices industry. Currently, SYK has a P/B value of 2.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SYK
Add Stryker Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SYK